Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of losmapimod in non-ST elevation myocardial infarction (NSTEMI)
2009-010615-32Phase 2Completed
- Sponsor
- GSK
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Non-ST-segment elevation myocardial infarction (NSTEMI) comparing Losmapimod with Placebo (2 arms). Primary endpoint: Safety endpoints. Started May 2009; status: completed.
02
Drugs
losmapimod
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2009-010615-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010615-32.